Nasdaq · CIK 0001506492
NUWE Nuwellis, Inc.
Insider trading from SEC Form 4. Last filing Apr 29, 2026.
In brief
Nuwellis, Inc. (NUWE) has 10 SEC Form 4 filings on file from 6 insiders, the latest filed on Apr 29, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Nuwellis, Inc., scored.
Transactions
Every row filed, 14 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Martin J Emerson director | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +6,744 | $0.00 | $0 | 6,744 | Apr 29, 2026 |
| Apr 28, 2026 | Archelle Georgiou Feldshon director | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +6,744 | $0.00 | $0 | 6,744 | Apr 29, 2026 |
| Apr 28, 2026 | David McDonald director | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +6,744 | $0.00 | $0 | 6,744 | Apr 29, 2026 |
| Apr 28, 2026 | Gregory D Waller director | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +6,744 | $0.00 | $0 | 6,744 | Apr 29, 2026 |
| Jun 27, 2025 | John L Erb CEO and President | AGrant or award Incentive Stock Option (right to buy)derivative | +115,329 | $0.00 | $0 | 115,329 | Jul 1, 2025 |
| Jun 9, 2025 | John L Erb CEO and President | CConversion Common Stock | +1,092,500 | $0.06 | $66k | 1,092,500 | Jun 11, 2025 |
| Jun 10, 2025 | John L Erb CEO and President | CConversion Common Stock | +7,522 | $0.06 | $451 | 1,100,022 | Jun 11, 2025 |
| Jun 9, 2025 | John L Erb CEO and President | JOther Series F Convertible Preferred Stockderivative | -100 | - | - | 0 | Jun 11, 2025 |
| Jun 9, 2025 | John L Erb CEO and President | JOther Series F-1 Convertible Preferred Stockderivative | +100 | - | - | 100 | Jun 11, 2025 |
| Jun 9, 2025 | John L Erb CEO and President | CConversion Series F-1 Convertible Preferred Stockderivative | -66 | - | - | 34 | Jun 11, 2025 |
| May 20, 2025 | Archelle Georgiou Feldshon director | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +17,496 | $0.00 | $0 | 17,496 | May 21, 2025 |
| May 20, 2025 | Michael Kendrick McCormick director | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +17,496 | $0.00 | $0 | 17,496 | May 21, 2025 |
| May 20, 2025 | David McDonald director | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +17,496 | $0.00 | $0 | 17,496 | May 21, 2025 |
| May 20, 2025 | Gregory D Waller director | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +17,496 | $0.00 | $0 | 17,496 | May 21, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- John L ErbCEO and President
- Martin J Emersondirector
- Archelle Georgiou Feldshondirector
- Michael Kendrick McCormickdirector
- David McDonalddirector
- Gregory D Wallerdirector
Questions about NUWE
Answered from the filings on this page, as of the latest one.
Are insiders buying NUWE?
No. In the last 90 days no insider at Nuwellis, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade NUWE on the open market?
No open-market trade has been scored at Nuwellis, Inc.. The latest Form 4 on file was filed on Apr 29, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Nuwellis, Inc.?
6 people have filed a Form 4 at Nuwellis, Inc., among them John L Erb (CEO and President), Martin J Emerson (director), Archelle Georgiou Feldshon (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.